Cinclus Pharma Holding AB (CINPHA) NPV

Sell:16.76 SEKBuy:17.06 SEKPrice increased0.10 SEK (0.59%)

Prices delayed by at least 15 minutes
Sell:16.76 SEK
Buy:17.06 SEK
Change:Price increased0.10 SEK (0.59%)
Deal now
Prices delayed by at least 15 minutes
Sell:16.76 SEK
Buy:17.06 SEK
Change:Price increased0.10 SEK (0.59%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open16.84 SEK
Previous close16.94 SEK
Market capSEK 788.35m
P/E ratio-
Volume12,891
Dividend yield0.00%
EMS-

Company information

Cinclus Pharma Holding AB (publ) (Cinclus Pharma) is a Sweden-based research based biotech company developing small molecules for the treatment of gastric acid related diseases. The Company is developing linaprazan ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue46.54m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 546.56m
Total liabilitiesSEK 177.17m
Net debt-SEK 479.36m

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.